BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6291761)

  • 21. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
    Wang BS; McLoughlin GA; Richie JP; Mannick JA
    Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of immune status on the metastasis of three murine fibrosarcomas of different immunogenicities.
    Fidler IJ; Gersten DM; Kripke ML
    Cancer Res; 1979 Oct; 39(10):3816-21. PubMed ID: 476618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
    J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic variants of the B16 melanoma: metastasis is related to environmental conditions. Phenotypic changes in vitro and metastatic colonization potential in nude mice.
    Aubert C
    Melanoma Res; 1995 Jun; 5(3):139-46. PubMed ID: 7640514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo isolation of a metastatic tumor cell variant involving selective and nonadaptive processes.
    Raz A; Hanna N; Fidler IJ
    J Natl Cancer Inst; 1981 Jan; 66(1):183-9. PubMed ID: 6935459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between cellular procoagulant activity and metastatic capacity of B16 mouse melanoma variants.
    Gilbert LC; Gordon SG
    Cancer Res; 1983 Feb; 43(2):536-40. PubMed ID: 6848176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental metastasis: a novel application of the variance-to-mean power function.
    Kendal WS; Frost P
    J Natl Cancer Inst; 1987 Nov; 79(5):1113-5. PubMed ID: 3479636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    Hanna N; Schneider M
    J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases.
    Poste G; Doll J; Brown AE; Tzeng J; Zeidman I
    Cancer Res; 1982 Jul; 42(7):2770-8. PubMed ID: 7083167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor cell hybridization and neoplastic progression.
    Hart IR
    Symp Fundam Cancer Res; 1983; 36():133-43. PubMed ID: 6382503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against experimental cerebral metastases of murine melanoma B16 by active immunization.
    Staib L; Harel W; Mitchell MS
    Cancer Res; 1993 Mar; 53(5):1113-21. PubMed ID: 8439956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of metastatic potential of mouse B16-melanoma cells to lung after treatment with gangliosides of B-16-melanoma cells of higher metastatic potential to lung.
    Saha S; Mohanty KC
    Indian J Exp Biol; 2003 Nov; 41(11):1253-8. PubMed ID: 15332492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for paracrine regulation of experimental metastasis in 13762NF rat mammary adenocarcinoma cell clones.
    Welch DR; Aeed PA; Earhart RH; McClure SA
    Anticancer Res; 1994; 14(5A):1743-51. PubMed ID: 7847807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is tumor cell radiation resistance correlated with metastatic ability?
    Suit H; Allam A; Allalunis-Turner J; Brock W; Girinsky T; Hill S; Hunter N; Milas L; Pearcey R; Peters L
    Cancer Res; 1994 Apr; 54(7):1736-41. PubMed ID: 8137288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
    Pan JP; Weng YS; Wu QQ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abrogation of hematogenous metastases in a murine model by natural killer cells.
    Richie JP
    Surgery; 1984 Aug; 96(2):133-8. PubMed ID: 6463854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secretion of metastasis related gangliosides by mouse B16-melanoma in circulation in vivo and in culture media in vitro.
    Saha S; Mohanty KC
    Indian J Exp Biol; 2004 Oct; 42(10):976-80. PubMed ID: 15511000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. I. Effect of incompatibilities at H-2 or non-H-2 genes in normal and nude (nu/nu) mice.
    Schirrmacher V
    Invasion Metastasis; 1981; 1(1):4-21. PubMed ID: 7188381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.
    Morecki S; Yacovlev E; Gelfand Y; Uzi I; Slavin S
    J Immunother; 2001; 24(2):114-21. PubMed ID: 11265768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery.
    Da Costa ML; Redmond HP; Bouchier-Hayes DJ
    J Surg Res; 2001 Dec; 101(2):111-9. PubMed ID: 11735264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.